» Articles » PMID: 25464848

Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells Through Rac1 Activation

Overview
Journal Cell Rep
Publisher Cell Press
Date 2014 Dec 4
PMID 25464848
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Different cancer cell compartments often communicate through soluble factors to facilitate tumor growth. Glioma stem cells (GSCs) are a subset of tumor cells that resist standard therapy to contribute to disease progression. How GSCs employ a distinct secretory program to communicate with and nurture each other over the nonstem tumor cell (NSTC) population is not well defined. Here, we show that GSCs preferentially secrete Sema3C and coordinately express PlexinA2/D1 receptors to activate Rac1/nuclear factor (NF)-κB signaling in an autocrine/paracrine loop to promote their own survival. Importantly, Sema3C is not expressed in neural progenitor cells (NPCs) or NSTCs. Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma. Introduction of activated Rac1 rescued the Sema3C knockdown phenotype in vivo. Our study supports the targeting of Sema3C to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index.

Citing Articles

Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma.

Li H, Qiao L, Kong M, Fang H, Yan Z, Guo R Sci Rep. 2024; 14(1):26994.

PMID: 39506070 PMC: 11541849. DOI: 10.1038/s41598-024-78467-3.


The metastasis-promoting P1597L mutation in PlexinB1 enhances Ras activity.

Garg R, Williamson M BMC Cancer. 2024; 24(1):1004.

PMID: 39138404 PMC: 11321201. DOI: 10.1186/s12885-024-12762-0.


Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression.

Peng H, Yang M, Feng K, Lv Q, Zhang Y Signal Transduct Target Ther. 2024; 9(1):169.

PMID: 38956074 PMC: 11220018. DOI: 10.1038/s41392-024-01887-0.


Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements.

Iniguez-Munoz S, Llinas-Arias P, Ensenyat-Mendez M, Bedoya-Lopez A, Orozco J, Cortes J Cell Mol Life Sci. 2024; 81(1):274.

PMID: 38902506 PMC: 11335195. DOI: 10.1007/s00018-024-05314-z.


Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.

Tam K, Liu L, Hsing M, Dalal K, Thaper D, McConeghy B Sci Rep. 2024; 14(1):7082.

PMID: 38528115 PMC: 10963789. DOI: 10.1038/s41598-024-57854-w.


References
1.
Stewart M, Grippon S, Kirkpatrick P . Aflibercept. Nat Rev Drug Discov. 2012; 11(4):269-70. DOI: 10.1038/nrd3700. View

2.
Kaibuchi K, Kuroda S, Amano M . Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 2000; 68:459-86. DOI: 10.1146/annurev.biochem.68.1.459. View

3.
Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S . A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012; 488(7412):522-6. PMC: 3427400. DOI: 10.1038/nature11287. View

4.
Martin-Satue M, Blanco J . Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol. 1999; 72(1):18-23. DOI: 10.1002/(sici)1096-9098(199909)72:1<18::aid-jso5>3.0.co;2-p. View

5.
Pastrana E, Silva-Vargas V, Doetsch F . Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 2011; 8(5):486-98. PMC: 3633588. DOI: 10.1016/j.stem.2011.04.007. View